Clinical trial
The Safety and Efficacy of Risperidone as Adjunctive Therapy to Mood Stabilizers…
NCT00216554 · Janssen Korea, Ltd., Korea, Industry · Completed
Key facts
| NCT number | NCT00216554 |
|---|---|
| Title | The Safety and Efficacy of Risperidone as Adjunctive Therapy to Mood Stabilizers in the Long-term Treatment of Bipolar Mania |
| Official title | A Multicenter, Open-Label Study to Evaluate Safety and Efficacy of Risperidone as Adjunctive Therapy to Mood Stabilizers in the Long-term Treatment of Bipolar Mania |
| Lead sponsor | Janssen Korea, Ltd., Korea, Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Bipolar Disorder |
| Intervention type | Drug |
| Interventions | risperidone |
| Enrollment | 118 |
| Start date | Sep 1, 2004 |
| Completion | Mar 1, 2006 |
| First posted | Sep 22, 2005 |
| Last update posted | Jan 24, 2011 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: